These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20562403)

  • 1. Delayed onset of a second paraneoplastic neurological syndrome in eight patients.
    Ducray F; Graus F; Vigliani MC; Antoine JC; Rogemond V; Saiz A; Honnorat J
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):937-9. PubMed ID: 20562403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
    Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
    Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
    Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
    J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.
    Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
    Fu P; He L; Tang N; Nie Q; Li Z
    J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
    Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
    J Biosci; 2021; 46():. PubMed ID: 33709965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes.
    Stich O; Klages E; Bischler P; Jarius S; Rasiah C; Voltz R; Rauer S
    Acta Neurol Scand; 2012 May; 125(5):326-31. PubMed ID: 21751968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
    Stich O; Rasiah C; Rauer S
    Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.
    Zhang L; Qian W; Chen Q; Yin L; Li B; Wang H
    Cell Immunol; 2014 Aug; 290(2):245-50. PubMed ID: 25173445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases.
    Hoffmann LA; Jarius S; Pellkofer HL; Schueller M; Krumbholz M; Koenig F; Johannis W; la Fougere C; Newman T; Vincent A; Voltz R
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):767-73. PubMed ID: 18223018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid study in paraneoplastic syndromes.
    Psimaras D; Carpentier AF; Rossi C;
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):42-5. PubMed ID: 19324868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological paraneoplastic syndromes in lung cancer patients.
    Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
    Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
    Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
    Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of circulating anti-Hu antibody in serial samples from patients with paraneoplastic neurological syndromes: possible correlation of antibody concentration and course of neurological symptoms.
    Rauer S; Czygan M; Kaiser R
    J Neurol; 2002 Mar; 249(3):285-9. PubMed ID: 11993527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onconeural antibodies in patients with neurological symptoms: detection and clinical significance.
    Raspotnig M; Vedeler CA; Storstein A
    Acta Neurol Scand Suppl; 2011; (191):83-8. PubMed ID: 21711262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.